DBP B — Double Bond Pharmaceutical International AB (publ) Balance Sheet
0.000.00%
Last trade - 00:00- SEK28.74m
- SEK26.22m
- SEK1.09m
Annual balance sheet for Double Bond Pharmaceutical International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 15.5 | 12.6 | 2.6 | 3.93 | 3.99 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.23 | 2.12 | 2.5 | 0.753 | 0.975 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 22.2 | 18.7 | 6.5 | 5.02 | 5.6 |
| Net Property, Plant And Equipment | 0.095 | 0.351 | 0.258 | 0.166 | 0.087 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 22.8 | 27.8 | 15.4 | 11.6 | 12.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.5 | 3.9 | 3.32 | 6.24 | 8.35 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 5.5 | 3.9 | 3.32 | 6.24 | 8.35 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 17.3 | 23.9 | 12.1 | 5.36 | 4 |
| Total Liabilities & Shareholders' Equity | 22.8 | 27.8 | 15.4 | 11.6 | 12.4 |
| Total Common Shares Outstanding |